Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
BEXIMCO PHARMA.GDR REGS 1
R2WACurrent price
0.43 EUR
0 EUR (0.00%)
Last closed
0.42 EUR
Company
–
ISIN
US0885792061
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Frankfurt Exchange
Capitalization
196 228 036 EUR
Yield for 12 month
-1.39 %
1Y
3Y
5Y
10Y
15Y
R2WA
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh. Address: 19 Dhanmondi R/A, Dhaka, Bangladesh, 1205
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
3.71Dividend Yield
7.93 %Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures R2WA
1 year
3 years
5 years
10 years
EBITDA
10 175 602 825 EUR
Operating Margin TTM
PE Ratio
3.71
Return On Assets TTM
7.48 %
PEG Ratio
–
Return On Equity TTM
11.79 %
Wall Street Target Price
–
Revenue TTM
45 287 375 089 EUR
Book Value
109.65 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
13.00 %
Dividend Yield
7.93 %
Gross Profit TTM
16 031 109 741 EUR
Earnings per share
0.11 EUR
Diluted Eps TTM
0.11 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
51.00 %
Profit Margin
13.13 %
Dividend Analytics R2WA
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
109.00 %Consecutive Years
1 year5Y Average Payout Ratio
–Dividend History R2WA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.030
Ex Dividend Date
22.11.2024
Forward Annual Dividend Yield
8.36 %
Last Split Factor
1.1:1
Payout Ratio
29.75 %
Last Split Date
23.11.2020
Dividend Date
–
Stock Valuation R2WA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
3.71
Forward PE
4.23
Enterprise Value Revenue
0.92
Price Sales TTM
0.0043
Enterprise Value EBITDA
4.70
Price Book MRQ
0.48
Financials R2WA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators R2WA
For 52 weeks
0.22 EUR
0.46 EUR
50 Day MA
0.36 EUR
Shares Short Prior Month
–
200 Day MA
0.40 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart